
Sign up to save your podcasts
Or


The SPRINT study, suggesting that we aim for a systolic BP target of 120 mm Hg in high-risk hypertensive patients, has been published with much fanfare.
Dr. Paul Whelton — one of the SPRINT investigators — is our guest. He warns against setting 120 as a performance measure, observing that roughly half the patients in the aggressively treated group had levels above that.
Links:
NEJM article (free)
By NEJM Group4.5
5656 ratings
The SPRINT study, suggesting that we aim for a systolic BP target of 120 mm Hg in high-risk hypertensive patients, has been published with much fanfare.
Dr. Paul Whelton — one of the SPRINT investigators — is our guest. He warns against setting 120 as a performance measure, observing that roughly half the patients in the aggressively treated group had levels above that.
Links:
NEJM article (free)

7,598 Listeners

320 Listeners

2,059 Listeners

125 Listeners

496 Listeners

293 Listeners

885 Listeners

263 Listeners

3,341 Listeners

112,022 Listeners

90 Listeners

5 Listeners

92 Listeners

513 Listeners

2,550 Listeners

369 Listeners

15,835 Listeners

61 Listeners

31 Listeners

66 Listeners